Aurobindo Pharma Receives EIR For Unit VIII Of Gaddapotharam API Facility With VAI Status From USFDA

Aurobindo Pharma Ltd had earlier announced about the USFDA inspection of Unit VIII, API manufacturing facility at Gaddapotharam, Hyderabad. The Company has received the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAI) status from USFDA.

Shares of AUROBINDO PHARMA LTD. was last trading in BSE at Rs.504.1 as compared to the previous close of Rs. 503.85. The total number of shares traded during the day was 267771 in over 5295 trades.

The stock hit an intraday high of Rs. 520 and intraday low of 497.1. The net turnover during the day was Rs. 135791102.-Equity Bulls